Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

OMEPRAZOLE

OMEPRAZOLE

Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview OMEPRAZOLE is listed in Drugs@FDA under application 210070 (ANDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient OMEPRAZOLE Form and strength TABLET, DELAYED RELEASE;ORAL - 20MG Sponsor APOTEX Submission history Latest submission status date: 2020-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview OMEPRAZOLE is listed in Drugs@FDA under application 210070 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient OMEPRAZOLE Form and strength TABLET, DELAYED RELEASE;ORAL - 20MG Sponsor APOTEX Submission history Latest submission status date: 2020-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.